Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03767348
PHASE2

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Sponsor: Replimune Inc.

View on ClinicalTrials.gov

Summary

The Phase 2 study is a multicenter, open-label study of RP1 to further investigate safety and to estimate the efficacy of RP1 at the RP2D in combination with nivolumab in patients with Stage IIIb-IV unresectable melanoma, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors, non-melanoma skin cancer (NMSC), and non-small cell lung cancer (NSCLC).

Official title: An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors [IGNYTE]

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

340

Start Date

2017-09-20

Completion Date

2028-12

Last Updated

2026-02-13

Healthy Volunteers

No

Interventions

BIOLOGICAL

RP1

Genetically modified herpes simplex type 1 virus

BIOLOGICAL

nivolumab

anti-PD-1 monoclonal antibody

Locations (51)

University of Birmingham Alabama

Birmingham, Alabama, United States

Banner MD Anderson Cancer Center

Gilbert, Arizona, United States

Mayo Clinic

Phoenix, Arizona, United States

Carti Cancer Center

Little Rock, Arkansas, United States

UC San Diego

La Jolla, California, United States

University of Southern California

Los Angeles, California, United States

UCLA

Los Angeles, California, United States

University of California, Irvine

Orange, California, United States

University of California- San Francisco

San Francisco, California, United States

Sylvester Comprehensive Cancer Center- University of Miami

Miami, Florida, United States

University of Iowa-Cancer Center Research

Iowa City, Iowa, United States

James Graham Brown Cancer Center- University of Louisville

Louisville, Kentucky, United States

Mayo Clinic

Rochester, Minnesota, United States

New York University Clinical Cancer Center

New York, New York, United States

Weill Cornell Medical College

New York, New York, United States

University of Rochester Medical Center

Rochester, New York, United States

Duke Cancer Center

Durham, North Carolina, United States

University of Cincinnati Medical Center

Cincinnati, Ohio, United States

Providence Portland Medical Center

Portland, Oregon, United States

MUSC Health

Charleston, South Carolina, United States

West Cancer Center

Germantown, Tennessee, United States

The University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Eccles Outpatient Care Center- Oncology Clinical Trials

Murray, Utah, United States

Intermountain Cancer Center- Saint George Cancer Center

St. George, Utah, United States

Seattle Cancer Care Alliance- University of Washington

Seattle, Washington, United States

University of Wisconsin-Carbone Cancer Center

Madison, Wisconsin, United States

CHU Besancon - Hopital Jean Minjoz

Besançon, France

Institut Bergonié

Bordeaux, France

CHU Dijon

Dijon, France

Centre Léon Bérard Lyon

Lyon, France

Service de Dermatologie et Cancerologie Cutanee Hopital de la Timone

Marseille, France

CHU de Nice Hôpital l'Archet

Nice, France

Hôpital Saint Louis APHP

Paris, France

Institut Gustave Roussy

Villejuif, France

Charité (Campus Benjamin Franklin)

Berlin, Germany

University Hospital Essen, Klinik für Dermatologie

Essen, Germany

University of Kiel (UKSH), Dep. of Dermatology

Kiel, Germany

Uniklinik Marburg

Marburg, Germany

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Hospital Clinic Barcelona

Barcelona, Spain

Clínica Universidad de Navarra (Madrid)

Madrid, Spain

Hospital Universitario Virgen de la Arrixaca

Murcia, Spain

Clinica Universitaria de Navarra

Pamplona, Spain

Hospital Universitario Virgen del Rocio

Seville, Spain

Hospital General Universitario de Valencia

Valencia, Spain

University of Leeds- Teaching Hospital

Leeds, England, United Kingdom

Oxford University Hospitals NHS Trust

Oxford, Oxfordshire, United Kingdom

Beatson West of Scotland Cancer Center

Glasgow, Scotland, United Kingdom

The Clatterbridge Cancer Centre NHS Foundation Trust

Bebington, Wirral, United Kingdom

Royal Marsden Hospital

London, United Kingdom

Southampton General Hospital

Southampton, United Kingdom